Figure 4
(A) ROC curve of serum DSG2 for patients with ESCC and early-stage ESCC versus healthy controls in the training cohort. (B) ROC curve of serum DSG2 for patients with ESCC and early-stage ESCC versus healthy controls in the validation cohort. (C) ROC curve of serum DSG2 for patients with ESCC and early-stage ESCC versus healthy controls in the joint cohort. (D) ROC curve of serum DSG2 for patients with EJA and early-stage EJA versus healthy controls.
ROC curve analysis of serum DSG2 for the diagnosis of ESCC and EJA

(A) ROC curve of serum DSG2 for patients with ESCC and early-stage ESCC versus healthy controls in the training cohort. (B) ROC curve of serum DSG2 for patients with ESCC and early-stage ESCC versus healthy controls in the validation cohort. (C) ROC curve of serum DSG2 for patients with ESCC and early-stage ESCC versus healthy controls in the joint cohort. (D) ROC curve of serum DSG2 for patients with EJA and early-stage EJA versus healthy controls.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept